• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Low-Dose Digoxin and Reduction in Mortality and Morbidity in Heart Failure.低剂量地高辛与心力衰竭死亡率和发病率的降低
Int J Cardiol. 2009 Jul 24;136(1):91-92. doi: 10.1016/j.ijcard.2008.06.083.
2
Association of serum digoxin concentration with morbidity and mortality in patients with atrial fibrillation, heart failure and reduced ejection fraction of 45 % or below.血清地高辛浓度与 45%或以下射血分数的心房颤动、心力衰竭患者发病率和死亡率的关系。
Curr Probl Cardiol. 2024 Feb;49(2):102218. doi: 10.1016/j.cpcardiol.2023.102218. Epub 2023 Nov 23.
3
Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.地高辛对舒张性心力衰竭发病率和死亡率的影响：洋地黄辅助研究组试验
Circulation. 2006 Aug 1;114(5):397-403. doi: 10.1161/CIRCULATIONAHA.106.628347. Epub 2006 Jul 24.
4
Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial.小剂量地高辛治疗心力衰竭患者的疗效和安全性。DECISION 试验的原理和设计。
Eur J Heart Fail. 2024 Oct;26(10):2223-2230. doi: 10.1002/ejhf.3428. Epub 2024 Aug 30.
5
Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial.地高辛血清浓度与死亡率结局相关性的剂量反应特征： DIG 试验研究。
Eur J Heart Fail. 2016 Aug;18(8):1072-81. doi: 10.1002/ejhf.584.
6
The effect of digoxin on mortality and morbidity in patients with heart failure.地高辛对心力衰竭患者死亡率和发病率的影响。
N Engl J Med. 1997 Feb 20;336(8):525-33. doi: 10.1056/NEJM199702203360801.
7
Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.循证治疗能否为已经接受血管紧张素转换酶抑制剂治疗的充血性心力衰竭患者带来额外益处？赖诺普利治疗与生存评估（ATLAS）研究一年期结果的二次分析。
Clin Ther. 2004 May;26(5):694-703. doi: 10.1016/s0149-2918(04)90069-0.
8
Digoxin may reduce the mortality rates in patients with congestive heart failure.地高辛可能降低充血性心力衰竭患者的死亡率。
Med Hypotheses. 2005;64(1):124-6. doi: 10.1016/j.mehy.2004.02.058.
9
Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure.心肌钠钾ATP酶：地高辛治疗充血性心力衰竭血流动力学效应的分子基础。
Cardiovasc Res. 2002 Sep;55(4):710-3. doi: 10.1016/s0008-6363(02)00466-2.
10
Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function.伊伐布雷定与低剂量地高辛治疗左心室收缩功能保留的舒张性心力衰竭的比较。
Clin Pract. 2013 Nov 4;3(2):e29. doi: 10.4081/cp.2013.e29. eCollection 2013 Aug 2.

引用本文的文献

1
Improvement of Adequate Digoxin Dosage: An Application of Machine Learning Approach.优化地高辛剂量：机器学习方法的应用。
J Healthc Eng. 2018 Aug 19;2018:3948245. doi: 10.1155/2018/3948245. eCollection 2018.
2
Beta-blockers or Digoxin for Atrial Fibrillation and Heart Failure?β受体阻滞剂还是地高辛用于心房颤动和心力衰竭？
Card Fail Rev. 2016 May;2(1):35-39. doi: 10.15420/cfr.2015:28:2.
3
Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac Injury.地高辛介导的RGS2蛋白上调可预防心脏损伤。
J Pharmacol Exp Ther. 2016 May;357(2):311-9. doi: 10.1124/jpet.115.231571. Epub 2016 Mar 3.
4
Intermittent low-dose digoxin may be effective and safe in patients with chronic heart failure undergoing maintenance hemodialysis.对于接受维持性血液透析的慢性心力衰竭患者，间歇性小剂量地高辛可能有效且安全。
Exp Ther Med. 2014 Dec;8(6):1689-1694. doi: 10.3892/etm.2014.2013. Epub 2014 Oct 9.
5
Cardiotonic steroids stabilize regulator of G protein signaling 2 protein levels.强心甾体稳定 G 蛋白信号转导调节剂 2 蛋白水平。
Mol Pharmacol. 2012 Sep;82(3):500-9. doi: 10.1124/mol.112.079293. Epub 2012 Jun 13.

本文引用的文献

1
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.奈必洛尔在老年心力衰竭患者中的耐受性及剂量相关效应：来自奈必洛尔干预对老年心力衰竭患者结局和再住院率影响的研究（SENIORS）试验的数据
Am Heart J. 2007 Jul;154(1):109-15. doi: 10.1016/j.ahj.2007.03.025.
2
Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations.地高辛与老年心力衰竭患者死亡率及住院率的降低：低剂量和低血清浓度的重要性
J Gerontol A Biol Sci Med Sci. 2007 Mar;62(3):323-9. doi: 10.1093/gerona/62.3.323.
3
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial.低血清浓度地高辛对心力衰竭患者死亡率和住院率的影响：一项针对地高辛研究（DIG 试验）的倾向匹配研究
Int J Cardiol. 2008 Jan 11;123(2):138-46. doi: 10.1016/j.ijcard.2006.12.001. Epub 2007 Mar 23.
4
The underuse of digoxin in heart failure, and approaches to appropriate use.心力衰竭中地高辛的使用不足及合理使用方法。
CMAJ. 2007 Feb 27;176(5):641-3. doi: 10.1503/cmaj.061239.
5
Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.地高辛对舒张性心力衰竭发病率和死亡率的影响：洋地黄辅助研究组试验
Circulation. 2006 Aug 1;114(5):397-403. doi: 10.1161/CIRCULATIONAHA.106.628347. Epub 2006 Jul 24.
6
Contemporary use of digoxin in the management of cardiovascular disorders.地高辛在心血管疾病管理中的当代应用。
Circulation. 2006 May 30;113(21):2556-64. doi: 10.1161/CIRCULATIONAHA.105.560110.
7
Acute heart failure syndromes: current state and framework for future research.急性心力衰竭综合征：现状与未来研究框架
Circulation. 2005 Dec 20;112(25):3958-68. doi: 10.1161/CIRCULATIONAHA.105.590091.
8
Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.地高辛与心力衰竭患者死亡率及住院率的降低：地高辛研究（DIG）的全面事后分析
Eur Heart J. 2006 Jan;27(2):178-86. doi: 10.1093/eurheartj/ehi687. Epub 2005 Dec 8.
9
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).随机试验以确定奈必洛尔对老年心力衰竭患者死亡率和心血管疾病住院率的影响（SENIORS研究）
Eur Heart J. 2005 Feb;26(3):215-25. doi: 10.1093/eurheartj/ehi115. Epub 2005 Jan 9.
10
Use of beta-blockers in older adults with chronic heart failure.
Am J Med Sci. 2004 Aug;328(2):100-11. doi: 10.1097/00000441-200408000-00006.

Low-Dose Digoxin and Reduction in Mortality and Morbidity in Heart Failure.

作者信息

Ahmed Ali, Waagstein Finn

机构信息

University of Alabama at Birmingham and VA Medical Center, Birmingham, AL, USA.

出版信息

Int J Cardiol. 2009 Jul 24;136(1):91-92. doi: 10.1016/j.ijcard.2008.06.083.

DOI:10.1016/j.ijcard.2008.06.083
PMID:20640177
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2904633/
Abstract
摘要